Effect of Intravascular Ultrasound-Guided vs Angiography-Guided Everolimus-Eluting Stent Implantation The IVUS-XPL Randomized Clinical Trial
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hong, Sung-Jin | - |
dc.contributor.author | Kim, Byeong-Keuk | - |
dc.contributor.author | Shin, Dong-Ho | - |
dc.contributor.author | Nam, Chung-Mo | - |
dc.contributor.author | Kim, Jung-Sun | - |
dc.contributor.author | Ko, Young-Guk | - |
dc.contributor.author | Choi, Donghoon | - |
dc.contributor.author | Kang, Tae-Soo | - |
dc.contributor.author | Kang, Woong-Chol | - |
dc.contributor.author | Her, Ae-Young | - |
dc.contributor.author | Kim, Yonghoon | - |
dc.contributor.author | Hur, Seung-Ho | - |
dc.contributor.author | Hong, Bum-Kee | - |
dc.contributor.author | Kwon, Hyuckmoon | - |
dc.contributor.author | Jang, Yangsoo | - |
dc.contributor.author | Hong, Myeong-Ki | - |
dc.date.available | 2020-02-28T07:42:52Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2015-11-24 | - |
dc.identifier.issn | 0098-7484 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/9924 | - |
dc.description.abstract | IMPORTANCE Use of intravascular ultrasound (IVUS) promotes better clinical outcomes for coronary intervention in complex coronary lesions. However, randomized data demonstrating the clinical usefulness of IVUS are limited for lesions treated with drug-eluting stents. OBJECTIVE To determine whether the long-term clinical outcomes with IVUS-guided drug-eluting stent implantation are superior to those with angiography-guided implantation in patients with long coronary lesions. DESIGN, SETTING, AND PARTICIPANTS The Impact of Intravascular Ultrasound Guidance on Outcomes of Xience Prime Stents in Long Lesions (IVUS-XPL) randomized, multicenter trial was conducted in 1400 patients with long coronary lesions (implanted stent >= 28mm in length) between October 2010 and July 2014 at 20 centers in Korea. INTERVENTIONS Patients were randomly assigned to receive IVUS-guided (n = 700) or angiography-guided (n = 700) everolimus-eluting stent implantation. MAIN OUTCOMES AND MEASURES Primary outcome measure was the composite of major adverse cardiac events, including cardiac death, target lesion-related myocardial infarction, or ischemia-driven target lesion revascularization at 1 year, analyzed by intention-to-treat. RESULTS One-year follow-up was complete in 1323 patients (94.5%). Major adverse cardiac events at 1 year occurred in 19 patients (2.9%) undergoing IVUS-guided and in 39 patients (5.8%) undergoing angiography-guided stent implantation (absolute difference, -2.97% [95% CI, -5.14% to -0.79%]) (hazard ratio [HR], 0.48 [95% CI, 0.28 to 0.83], P =.007). The difference was driven by a lower risk of ischemia-driven target lesion revascularization in patients undergoing IVUS-guided (17 [2.5%]) compared with angiography-guided (33 [5.0%]) stent implantation (HR, 0.51 [95% CI, 0.28 to 0.91], P = .02). Cardiac death and target lesion-related myocardial infarction were not significantly different between the 2 groups. For cardiac death, there were 3 patients (0.4%) in the IVUS-guided group and 5 patients (0.7%) in the angiography-guided group (HR, 0.60 [95% CI, 0.14 to 2.52], P = .48). Target lesion-related myocardial infarction occurred in 1 patient (0.1%) in the angiography-guided stent implantation group (P = .32). CONCLUSIONS AND RELEVANCE Among patients requiring long coronary stent implantation, the use of IVUS-guided everolimus-eluting stent implantation, compared with angiography-guided stent implantation, resulted in a significantly lower rate of the composite of major adverse cardiac events at 1 year. These differences were primarily due to lower risk of target lesion revascularization. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | AMER MEDICAL ASSOC | - |
dc.relation.isPartOf | JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | - |
dc.subject | EXPERT CONSENSUS DOCUMENT | - |
dc.subject | MYOCARDIAL-INFARCTION | - |
dc.subject | CORONARY LESIONS | - |
dc.subject | OUTCOMES | - |
dc.subject | THROMBOSIS | - |
dc.subject | GUIDANCE | - |
dc.subject | RESTENOSIS | - |
dc.subject | IMPACT | - |
dc.subject | PREDICTORS | - |
dc.subject | UNDEREXPANSION | - |
dc.title | Effect of Intravascular Ultrasound-Guided vs Angiography-Guided Everolimus-Eluting Stent Implantation The IVUS-XPL Randomized Clinical Trial | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000365351900019 | - |
dc.identifier.doi | 10.1001/jama.2015.15454 | - |
dc.identifier.bibliographicCitation | JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, v.314, no.20, pp.2155 - 2163 | - |
dc.identifier.scopusid | 2-s2.0-84948162604 | - |
dc.citation.endPage | 2163 | - |
dc.citation.startPage | 2155 | - |
dc.citation.title | JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | - |
dc.citation.volume | 314 | - |
dc.citation.number | 20 | - |
dc.contributor.affiliatedAuthor | Kang, Woong-Chol | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | EXPERT CONSENSUS DOCUMENT | - |
dc.subject.keywordPlus | MYOCARDIAL-INFARCTION | - |
dc.subject.keywordPlus | CORONARY LESIONS | - |
dc.subject.keywordPlus | OUTCOMES | - |
dc.subject.keywordPlus | THROMBOSIS | - |
dc.subject.keywordPlus | GUIDANCE | - |
dc.subject.keywordPlus | RESTENOSIS | - |
dc.subject.keywordPlus | IMPACT | - |
dc.subject.keywordPlus | PREDICTORS | - |
dc.subject.keywordPlus | UNDEREXPANSION | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.